일개 국립결핵병원에 입원치료를 받은 폐결핵환자의 임상양태에 관한 연구 - 1995년과 2002년 비교연구 -

Clinical Observational study of Pulmonary Tuberculosis for admitted patients at a National Tuberculosis Hospital - Comparison with the previous results in 1995 -

  • 박승규 (국립마산결핵병원 임상연구소) ;
  • 이인희 (국립마산결핵병원 임상연구소) ;
  • 김병주 (국립마산결핵병원 임상연구소)
  • Park, Seung-Kyu (Clinical Research Center for Tuberculosis, National Masan Tuberculosis Hospital) ;
  • Lee, In-Hee (Clinical Research Center for Tuberculosis, National Masan Tuberculosis Hospital) ;
  • Kim, Byoung-Ju (Clinical Research Center for Tuberculosis, National Masan Tuberculosis Hospital)
  • 투고 : 2004.12.09
  • 심사 : 2005.03.15
  • 발행 : 2005.04.30

초록

배 경 : 1995년 제7차 전국 결핵실태조사가 마지막으로 시행된 이 후 2000년 6월 결핵정보감시체계가 도입되었다. 결핵정보감시체계에서는 기존의 전국결핵실태조사에 포함된 균양성 유병율, 약제내성율 등 중요한 역학적 지표를 알 수 없는 한계를 가지고 있다. 본 연구의 목적은 1995년 12월과 2002년도 12월 국립마산결핵병원에 입원치료중인 환자의 임상양태를 조사 비교함으로 우리나라의 다제내성 결핵을 포함한 결핵실태추이의 한 단면을 알아보고자 함이었다. 방 법 : 2002년 12월 현재 국립마산결핵병원에 입원치료 중인 결핵환자 중 NTM으로 최종 확인된 6명을 제외한 331명을 대상으로 임상양태를 조사하고 이를 1995년에 보고된 자료와 비교조사 하였다. 결 과 : 1995년 자료와 비교할 때 평균연령은 3.6세 많았으며, 결핵치료 과거력과 이전 사용 약제 수는 각각 $2.0{\pm}1.7$회, $6.1{\pm}2.3$제에서 $1.7{\pm}1.8$회, $4.6{\pm}3.6$제로 감소하였다(각각 p<0.05, p<0.001). 전체적인 약제내성율은 비슷하였으나(81.0% vs 77.6%), 초회내성율과 초회다제내성율은 각각 10.5%와 2.4%에서 21.4%와 16.5%로 현저히 증가하였다(각각 p=0.012, p=0.001). 또한 1995년도에는 보건소에서 진단을 받은 경우가 65%였으나 2002년도에는 40.5%로 크게 감소하였다(p<0.001). 결 론 : 초회 내성율이 증가하고, 민간의료기관에서 진료하는 환자의 비중이 증가하는 등 우리나라의 결핵관리상황이 이전과 다르게 변해가고 있으므로 이에 대처할 수 있는 민간 및 공공의료기관이 협력할 수 있는 국가결핵관리프로그램의 수정 및 보완이 필요할 것으로 생각된다.

Background : The last national tuberculosis survey was carried out in 1995. In 2000, the KTBS(Korean Tuberculosis Surveillance System) replaced a previous national survey. However, the KTBS does not show some of the important epidemiological indexes such as the prevalence of positive tuberculosis or the drug resistance rate. The aim of this study was to compare the clinical features of pulmonary tuberculosis patients admitted to a national tuberculosis hospital in 1995 and 2002. From this study, the authors expect to estimate the trend of the clinical features of tuberculosis in Korea even though it can not represent the Korean tuberculosis situation as a whole. Method : A cross sectional analysis of the clinical features for 331 pulmonary tuberculosis in-patients admitted to the National Masan Tuberculosis Hospital as of Dec. 2002, was carried out and these results were compared with those reported in 1995. Results : In comparison with the data reported in 1995, the mean age was increased by 3.6 years ($44.1{\pm}14.6$ vs $47.7{\pm}16.4$, p<0.01). The number of past tuberculosis history and used anti-tuberculous drugs prior to admission decreased from $2.0{\pm}1.7$ and $6.1{\pm}2.3$ to $1.7{\pm}1.8$ and $4.6{\pm}3.6$(p<0.05, p<0.001), respectively. While the resistance rate for anti-tuberculous drugs was similar (81.0% vs 77.6%), the initial resistance rate(10.5% vs 21.4%) and initial MDR rate(2.4% vs 16.5%) increased significantly(p=0.012, p=0.001, respectively). In 1995, the public health communities were in charge of approximately 65% of newly diagnosed tuberculosis cases, but this reduced to 40.5% in 2002(p<0.001). Conclusion : The existing national TB program (NTP) needs to be revised and strengthened in order to cope with the unfavorably changing situation of the domestic TB problem because the number of TB patients has not decreased and the initial resistance rate has increased greatly. Furthermore, the public and private sectors should cooperate each other to control the TB problem effectively because the private sector is now managing more than half of the TB patients.

키워드

참고문헌

  1. Assessment of tuberculosis control work in Korea, 2003. Korea center for disease control and prevention, The Korean National Tuberculosis Association; 2004. p.1-20
  2. Kim SJ. The problem of initial drug resistance. Proceedings of the first congress of the Asian Pacific Society of Respirology; 1988. p.133-136
  3. Park SK, Choi IH, Kim CM, Kim CT, Song SD. Clinical study of pulmonary tuberculosis for admitted patients at National Masan TB Hospital. Tuberc Respir Dis 1997;44:241-50 https://doi.org/10.4046/trd.1997.44.2.241
  4. American Thoracic Society. Diagnostic standards and classification of tuberculosis. 12th ed. New York: National tuberculosis and respiratory disease association;1969
  5. Report of the 6th national tuberculosis prevalence survey. Ministry of health and social affairs, The Korean National Tuberculosis Association; 1991
  6. Tuberculosis in Korea (current situation and prospect). The Korean National Tuberculosis Association; 1993
  7. Guidelines for public health program. Ministry of health and social affairs; 1996. p.117
  8. Assessment of tuberculosis control work in Korea, 2003. Korea center for disease control and prevention, The Korean National Tuberculosis Association; 2004. p.1-8
  9. Lew WJ. Actual conditions of tuberculosis in Korea. Tuberc Respir Dis 2004;57(Suppl 1):203-9
  10. Population projection by age. Korea National Atatistical Office; 2004
  11. Kim SJ, Bai GH, Hong YP. Drug resistant tuberculosis in Korea. Int J Tuberc Lung Dis 1997;1:302-8
  12. Anti-tuberculosis drug resistance in the world. WHO/TB/1997. p.229
  13. Anti-tuberculosis drug resistance in the world (report No.2, prevalence and trends). WHO/CDC/TB/2000. p.27
  14. Park KD. Tuberclosis management of private health care institution current situation task. Tuberc Respir Dis 2002;52:579-89 https://doi.org/10.4046/trd.2002.52.6.579